Skip to content

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Glaukos logo
GlaukosGKOS
9.3×+2.0×
AbbVie logo
AbbVieABBV
261×+221×
Bausch + Lomb logo
Bausch + LombBLCO
0.9×+0.1×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
8.6×+2.4×
Boston Scientific logo
Boston ScientificBSX
3.6×-3.1×

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s price / book?
Sight Sciences, Inc. (SGHT) reported price / book of 3.8× in Q1 2026.
How has Sight Sciences, Inc.'s price / book changed year-over-year?
Sight Sciences, Inc.'s price / book increased by 138.0% year-over-year, from 1.6× to 3.8×.
What is the long-term trend for Sight Sciences, Inc.'s price / book?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s price / book has grown at a 16.2% compound annual growth rate (CAGR), from 3.6× to 6.6×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.